Literature DB >> 811966

Nonspecific resistance to Listeria monocytogenes in mice infected and elicited with Staphylococcus aureus.

R E Baughn.   

Abstract

Normal mice and mice displaying delayed hypersensitivity to Staphylococcus aureus were challenged with a lethal dose of Listeria monocytogenes. Nonspecific antimicrobial activity was assessed by inhibition of bacterial growth in the spleen and by increased survival rates. Administration of specific staphylococcal antigen prior to challenge was a prerequisite for the induction of nonspecific resistance. Both the time of administering eliciting antigen and the route were important consideration for evoking the response. Similar responses were seen in 3 strains of inbred mice following immunization with both encapsulated and nonencapsulated staphylococci. Although enhanced resistance as measured by viable counts in the spleens was achieved after 2 injections, protection as measured by survival required 4 injections of S. aureus followed by elicitation with staphylococcal antigens. Nonspecific resistance could be detected as late as 9 weeks after the disappearance of delayed hypersensitivity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811966     DOI: 10.1007/BF02122712

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  27 in total

1.  Lymphocyte mitogens of staphylococcal origin.

Authors:  A Taranta
Journal:  Ann N Y Acad Sci       Date:  1974-07-31       Impact factor: 5.691

2.  Cell-mediated immunity in mice infected with S. aureus and elicited with specific bacterial antigens.

Authors:  M Shayegani; S J De Courcy; S Mudd
Journal:  J Reticuloendothel Soc       Date:  1973-07

Review 3.  Resistance to intracellular infection.

Authors:  G B Mackaness
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

Review 4.  Cellular hypersensitivity and cellular immunity in the pathogensis of tuberculosis: specificity, systemic and local nature, and associated macrophage enzymes.

Authors:  A M Dannenberg
Journal:  Bacteriol Rev       Date:  1968-06

5.  Modification of macrophage function.

Authors:  R V Blanden
Journal:  J Reticuloendothel Soc       Date:  1968-06

6.  The phagocytosis and intracellular fate of staphylococci.

Authors:  F A Kapral
Journal:  Ann N Y Acad Sci       Date:  1965-07-23       Impact factor: 5.691

7.  Cell-mediated immune phenomena induced by lymphokines from splenic lymphocytes of mice with chronic staphylococcal infection.

Authors:  R E Baughin; P F Bonventre
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Staphylococcal delayed hypersensitivity in mice. II. In vitro demonstration and specificity of delayed hypersensitivity.

Authors:  J H Taubler; S Mudd
Journal:  J Immunol       Date:  1968-09       Impact factor: 5.422

9.  Immunobiological activity of cell wall antigens of Staphylococcus aureus.

Authors:  J J Kowalski; D T Berman
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  3 in total

1.  Delayed hypersensitivity to Staphylococcus aureus in mice: in vivo responses to isolated Staphylococcal antigens.

Authors:  J B Bolen; J L Tribble
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

2.  Staphylococcal PknB as the first prokaryotic representative of the proline-directed kinases.

Authors:  Malgorzata Miller; Stefanie Donat; Sonja Rakette; Thilo Stehle; Thijs R H M Kouwen; Sander H Diks; Annette Dreisbach; Ewoud Reilman; Katrin Gronau; Dörte Becher; Maikel P Peppelenbosch; Jan Maarten van Dijl; Knut Ohlsen
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

3.  Induction and specificity of delayed hypersensitivity to Staphylococcus aureus in mice.

Authors:  J L Tribble; J B Bolen
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.